Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL261P stands for "RNA, 7SL, cytoplasmic 261, pseudogene," and is classified as a **pseudogene** in the human genome[1][6]. Pseudogenes are genomic DNA sequences that closely resemble normal genes but are typically non-functional due to mutations or lack of regulatory elements required for expression[2]. The RN7SL261P gene specifically is a truncated, non-functional copy related to the functional 7SL RNA genes, which are part of the **signal recognition particle (SRP) RNA** family. The functional form of 7SL RNA is an essential component of the cytoplasmic SRP, a ribonucleoprotein complex involved in directing nascent proteins to the endoplasmic reticulum for secretion or membrane localization[5][7]. However, as a **pseudogene**, RN7SL261P does not encode a functional RNA and does not perform biological activity or participate in disease or drug interactions[1][6]. It is primarily of interest for genomic studies, evolutionary genetics, and as a potential confounder in molecular assays due to sequence similarity with functional SRP RNAs[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 261, pseudogene (RN7SL261P).